This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

March 14-17, 2022
San Diego Convention CenterSan Diego, California

Theodore Peters, Ph.D.
Senior Scientist, Bioprocess Development at Seagen


Ted has over five years of experience in the biopharmaceutical industry developing clonal CHO cell lines for the production of therapeutic antibodies. In his current role, Ted is interested in elucidating sources of genetic drift in CHO cells in an effort to identify cell lines that can maintain stable expression. Ted received his Ph.D. at the University of Colorado - Health Sciences Center and continued his training at the Buck Institute for Research on Aging as a postdoctoral scholar.

Agenda Sessions

  • Investigation of Gene Expression Patterns in Stable and Unstable Clonally-Derived CHO Cell Lines

  • Panel: Methods to Increase Stability of Cell Lines